Biofrontera Inc.
BFRI • NASDAQ
Biofrontera Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Hermann Luebbert, with a market cap of $12.1M.
Market Cap$12.1M
Employees85.0
CEOHermann Luebbert
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
BFR
Biofrontera Inc. FAQ
Common questions about Biofrontera Inc.
Biofrontera Inc. is scheduled to report earnings for Q1 2026 on May 14, 2026. Analysts estimate revenue of $10.0M.
Biofrontera Inc. has approximately 85 employees.